Prediction of the response to citalopram and reboxetine in post-stroke depressed patients: the reasons of the enrollment of patients without cognitive impairment

Author： Rampello Liborio   Alvano Alessandro  

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.175, Iss.2, 2004-09, pp. : 264-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prediction of the response to citalopram and reboxetine in post-stroke depressed patients

By Rampello Liborio   Chiechio Santina   Nicoletti Giovanni   Alvano Alessandro   Vecchio Ignazio   Raffaele Rocco   Malaguarnera Mariano  

Psychopharmacology, Vol. 173, Iss. 1-2, 2004-04 ,pp. : 73-78

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of cognitive impairment in patients with multiple sclerosis

By Patti Francesco  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 11, 2012-11 ,pp. : 1679-1699

Informa Healthcare

Access to resources Recommend Favorite

Cognitive Impairment and Dementia in Patients with Parkinson Disease

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-07 ,pp. : 903-912

Bentham Science Publishers

Access to resources Recommend Favorite

Global cognitive level and antidepressant efficacy in post-stroke depression

By Spalletta Gianfranco   Caltagirone Carlo  

Psychopharmacology, Vol. 175, Iss. 2, 2004-09 ,pp. : 262-263

Springer Publishing Company

Access to resources Recommend Favorite

Escitalopram in clinical practice in Greece: treatment response and tolerability in depressed patients

By Stamouli SS   Yfantis A   Lamboussis E   Liakouras A   Lagari V   Tzanakaki M   Giailoglou D   Legault M   Parashos IA  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 937-945

Informa Healthcare

Access to resources Recommend Favorite